相关实验视频
Updated: Jun 30, 2025

12:08
Diagonal Method to Measure Synergy Among Any Number of Drugs
Published on: June 21, 2018
18.6K
走向统一的人工智能药物发现与多模式知识
Yizhen Luo1,2, Xing Yi Liu1, Kai Yang1
1Institute for AI Industry Research (AIR), Tsinghua University, Beijing, China.
Health data science
|March 15, 2024
概括
本研究介绍了KEDD,这是一种用于AI药物发现的深度学习框架,集成了结构化和非结构化知识. KEDD增强了生物分子的理解,并加速了新疗法的发现.
科学领域:
- 计算化学是一种计算化学.
- 生物信息学是一种生物信息学.
- 人工智能在药物发现中的作用
背景情况:
- 人类专家利用多模式数据 (分子结构,知识库,文献) 进行药物发现.
- 当前的人工智能模型通常只集成结构化或非结构化知识,限制了整体的生物分子理解.
- 现有方法在新药和蛋白质的"缺失模式"问题上扎.
研究的目的:
- 为AI药物发现开发一个统一的深度学习框架 (KEDD).
- 为全面的生物分子分析共同整合结构化和非结构化知识.
- 为应对药物发现中缺少数据模式的挑战.
主要方法:
- 对于每个数据模式,KEDD使用独立的表示学习.
- 一种特征融合技术将信息结合起来进行预测.
- 稀疏的注意力和模式掩饰使用相关分子重建缺失的特征.
主要成果:
- 在多个AI药物发现任务中,KEDD表现出卓越的性能.
- 在药物向相互作用预测方面实现了5.2%的平均改善.
- 在药物特性 (2.6%),药物相互作用 (1.2%) 和蛋白质-蛋白质相互作用 (4.1%) 预测方面显示出显著的收益.
结论:
- KEDD有效地整合了多模式生物分子知识,以提高AI药物发现.
- 该框架显示了加速新药的识别和开发的潜力.
- 解决了多式联络药物发现方法中缺少数据的关键挑战.
相关概念视频
Drug Discovery: Overview
7.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.9K
Combined Effects of Drugs: Synergism
3.9K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.9K
Structure-Activity Relationships and Drug Design
716
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
716
Targets for Drug Action: Overview
6.2K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.2K
Combined Effects of Drugs: Antagonism
8.5K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
8.5K
Agonism and Antagonism: Quantification
369
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
369

